Inhibition of group a streptococcal infection by Melaleuca alternifolia (tea tree) oil concentrate in the murine model

Journal of Applied Microbiology

Volumn 108, Issue 3, 2010, Pages 936-944

  Tsao, N ^a   Kuo, C F ^a   Lei, H Y ^b   Lu, S L ^b   Huang, K J ^c  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

Experimental air pouch model; Mouse; Necrotizing fasciitis; Streptococcus pyogenes; Tea tree oil

Indexed keywords

GASES; MAMMALS; MICROWAVE INTEGRATED CIRCUITS;

AIR POUCH MODELS; BACTERICIDAL ACTIVITY; EXPERIMENTAL AIR POUCH MODEL; MELALEUCA ALTERNIFOLIA; MINIMAL INHIBITORY CONCENTRATION; MOUSE; MURINE MODEL; NECROTIZING FASCIITI; STREPTOCOCCUS PYOGENES; TEA TREE OIL;

MACROPHAGES;

CYTOKINE; TEA TREE OIL;

BACTERIAL DISEASE; BACTERIUM; BIOASSAY; GROWTH RATE; INFECTIOUS DISEASE; RODENT; SKIN; SURVIVAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXUDATE; FEMALE; GROUP A STREPTOCOCCAL INFECTION; GROWTH INHIBITION; IN VITRO STUDY; INFECTION SENSITIVITY; INFLAMMATION; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NECROTIZING FASCIITIS; NONHUMAN; PLASMA CLEARANCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES;

MELALEUCA ALTERNIFOLIA; MURINAE; MUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 76449107775     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2009.04487.x     Document Type: Article

References (29)

1. Bisno, A.L., Brito, M.O. Collins, C.M. (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3, 191 200.
2. Brand, C., Ferrante, A., Prager, R.H., Riley, T.V., Carson, C.F., Finlay-Jones, J.J. Hart, P.H. (2001) The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res 50, 213 219.
3. Brand, C., Grimbaldeston, M.A., Gamble, J.R., Drew, J., Finlay-Jones, J.J. Hart, P.H. (2002a) Tea tree oil reduces swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm Res 51, 236 244.
4. Brand, C., Townley, S.L., Finlay-Jones, J.J. Hart, P.H. (2002b) Tea tree oil reduces histamine-induced edema in murine ears. Inflamm Res 51, 283 289.
5. Caldefie-Chézet, F., Guerry, M., Chalchat, J.C., Fusillier, C., Vasson, M.P. Guillot, J. (2004) Anti-inflammatory effects of Melaleuca alternifolia essential oil on human polymorphonuclear neutrophils and monocytes. Free Radic Res 38, 805 811.
6. Caldefie-Chézet, F., Fusillier, C., Jarde, T., Laroye, H., Damez, M., Vasson, M.P. Guillot, J. (2006) Potential anti-inflammatory effects of Melaleuca alternifolia essential oil on human peripheral blood leukocytes. Phytother Res 20, 364 370.
7. Carson, C.F., Hammer, K.A. Riley, T.V. (2006) Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19, 50 62.
8. Collin, M. Olsen, A. (2003) Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 71, 2983 2992.
9. Cone, L.A., Woodard, D.R., Schlievert, P.M. Tomory, G.S. (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317, 146 149.
10. Cunningham, M.W. (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470 511.
11. Golab, M. Skwarlo-Sonta, K. (2007) Mechanisms involved in the anti-inflammatory action of inhaled tea tree oil in mice. Exp Biol Med 232, 420 426.
12. Hart, P.H., Brand, C., Carson, C.F., Riley, T.V., Prager, R.H. Finlay-Jones, J.J. (2000) Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res 49, 619 626.
13. Hayes, A.J., Leach, D.N. Markham, J.L. (1997) In vitro cytotoxicity of Australian tea tree oil using human cell lines. J Essent Oil Res 9, 575 582.
14. Khalil, Z., Pearce, A.L., Satkunanathan, N., Storer, E., Finlay-Jones, J.J. Hart, P.H. (2004) Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. J Invest Dermatol 123, 683 690.
15. Koh, K.J., Pearce, A.L., Marshman, G., Finlay-Jones, J.J. Hart, P.H. (2002) Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 147, 1212 1217.
16. Kuo, C.F., Luo, Y.H., Lin, H.Y., Huang, K.J., Wu, J.J., Lei, H.Y., Lin, M.T., Chuang, W.J. et al. (2004) Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection. Microb Pathog 36, 273 285.
17. Kuo, C.F., Wang, Y.H., Lei, H.Y., Wang, C.H. Tsao, N. (2007) Concanavalin A protects mice from a lethal inoculation of intragastric Klebsiella pneumoniae and reduces the induced liver damage. Antimicrob Agents Chemother 51, 3122 3130.
18. Kuo, C.F., Lin, Y.S., Chuang, W.J., Wu, J.J. Tsao, N. (2008) Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect Immun 76, 1163 1169.
19. McMahon, M.A.S., Blair, I.S., Moore, J.E. McDowell, D.A. (2007) Habituation to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia) is associated with reduced susceptibility to antibiotics in human pathogens. J Antimicrob Chemother 59, 125 127.
20. Nielsen, J.B. Nielsen, F. (2006) Topical use of tea tree oil reduces the dermal absorption of benzoic acid and methiocarb. Arch Dermatol Res 297, 395 402.
21. von Pawel-Rammingen, U. Bjorck, L. (2003) IdeS and SpeB: immunoglobulin- degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol 6, 50 55.
22. Pearce, A.L., Finlay-Jones, J.J. Hart, P.H. (2005) Reduction of nickel-induced contact hypersensitivity reactions by topical tea tree oil in humans. Inflamm Res 54, 22 30.
23. Stevens, D.L. (2000) Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 51, 271 288.
24. Sumby, P., Barbian, K.D., Gardner, D.J., Whitney, A.R., Welty, D.M., Long, R.D., Bailey, J.R., Parnell, M.J. et al. (2005) Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A 102, 1679 1684.
25. Tsao, N., Luh, T.Y., Chou, C.K., Wu, J.J., Lin, Y.S. Lei, H.Y. (2001) Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob Agents Chemother 45, 1788 1793.
26. Tsao, N., Tsai, W.H., Lin, Y.S., Chuang, W.J., Wang, C.H. Kuo, C.F. (2006) Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement- mediated opsonophagocytosis. Biochem Biophys Res Commun 339, 779 784.
27. Veien, N.K., Rosner, K. Skovgaard, G. (2004) Is tea tree oil an important contact allergen? Contact Dermatitis 50, 378 379.
28. Voyich, J.M., Musser, J.M. DeLeo, F.R. (2004) Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 6, 1117 1123.
29. Weiss, K.A. Laverdiere, M. (1997) Group A streptococcus invasive infection: a review. Can J Surg 40, 18 25.